01Postherpetic neuralgia programs
Pooled postherpetic neuralgia trials enrolled 852 people on LYRICA and 398 people on placebo. Premature discontinuation because of adverse reactions was 14% on LYRICA and 7% on placebo. Those programs enrolled people whose neuralgia had lasted at least 3 months after the zoster rash healed. A minimum baseline pain score of 4 on an 11-point scale was required.